Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology

被引：10
|
作者：
Piotrowski, Dariusz [1 ]
Przybylska-Baluta, Zofia [1 ]
Jimenez-Marco, Teresa [2 ]
Kryzauskaite, Lina [3 ]
Papachronis, Andreas [4 ]
Marinaki, Aliki [4 ]
Hoecker, Paul [5 ]
Cherrier-De Wilde, Sigrid [6 ]
Cardoso, Marcia [7 ]
机构：
[1] Reg Blood Transfus Ctr, Warsaw, Poland
[2] Blood & Tissue Bank Fdn Balear Isl, Palma De Afallorra, Spain
[3] Vilnius Univ Hosp Santariskiu Klin, Vilnius, Lithuania
[4] Laiko Hosp, Athens, Greece
[5] EUROPLASMA, Vienna, Austria
[6] Ctr Hosp Luxembourg, Luxembourg, Luxembourg
[7] Terumo BCT Europe, Zaventem, Belgium
来源：
BLOOD TRANSFUSION | 2018年 / 16卷 / 04期
关键词：
haemovigilance; pathogen reduction technology; blood components; TRANSFUSIONS;
D O I：
10.2450/2017.0268-16
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：348 / 351
页数：4
相关论文
共 50 条
  • [31] Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light
    Ragan, Izabela K. K.
    Hartson, Lindsay M. M.
    Sullivan, Elizabeth J. J.
    Bowen, Richard A. A.
    Goodrich, Raymond P. P.
    [J]. PLOS ONE, 2023, 18 (01):
  • [32] Pathogen Reduction Technology (PRT) for buffy coat platelet concentrates using riboflavin and light: Comparisons to PRT treated apheresis platelet products
    Li, J
    De Korte, D
    Woolum, MD
    Keil, SD
    Goodrich, RP
    [J]. TRANSFUSION, 2004, 44 (09) : 149A - 150A
  • [33] Improvement of Blood Processing and Safety by Automation and Pathogen Reduction Technology
    Perez Aliaga, Ana Isabel
    Labata, Gorka
    Aranda, Alfonso
    Cardoso, Marcia
    Puente, Fernando
    Domingo, Jose Maria
    Garces, Carmen
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (05) : 290 - 297
  • [34] Improving blood safety and patient outcomes with pathogen reduction technology
    Goodrich, Raymond P.
    Ettinger, Anna
    Radziwon, Piotr M.
    Rock, Gail
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (03) : 229 - 238
  • [35] Pathogen Reduction in Whole Blood with Riboflavin and Ultraviolet Light Does Not Affect Platelet Count or Function
    Pidcoke, H. F.
    Delgado, K. K.
    Mora, A. G.
    Reddy, H. L.
    Goodrich, R.
    Cap, A. P.
    [J]. TRANSFUSION, 2011, 51 : 64A - 65A
  • [36] Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes
    Tran, Johnson Q.
    Muench, Marcus O.
    Heitman, John W.
    Jackman, Rachael P.
    [J]. TRANSFUSION, 2019, 59 (11) : 3501 - 3510
  • [37] EVALUATION OF CYTOKINE ACCUMULATION IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS
    Castrillo, A.
    Abad, M. L.
    Arcas, C.
    Costoya, S.
    Rodriguez, M., I
    [J]. VOX SANGUINIS, 2010, 99 : 250 - 251
  • [38] Evaluation of the quality of Apheresis platelets treated with Mirasol® pathogen reduction technology
    Eakins, E.
    Murphy, C.
    Croxon, H.
    Birhire, R.
    Flynn, N.
    Taylor, S.
    Murphy, W.
    [J]. TRANSFUSION, 2008, 48 (02) : 21A - 21A
  • [39] Effectiveness of a riboflavin and light based Pathogen Reduction Technology (PRT) system to eliminate Babesia microti from apheresis platelets and plasma
    Tonnetti, Laura
    Proctor, Melanie C.
    Reddy, Heather L.
    Goodrich, Raymond P.
    Leiby, David A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 173 - 173
  • [40] Effectiveness of a riboflavin and light based pathogen reduction technology (PRT) system to eliminate babesia microti from apheresis platelets and plasma
    Tonnetti, L.
    Proctor, M.
    Reddy, H.
    Goodrich, R.
    Leiby, D.
    [J]. VOX SANGUINIS, 2008, 95 : 9 - 9
12345